Table 3.

Spearman correlations between TMAO and MRI indices 4 months post-STEMI stratified by eGFR.

	Reduced eGFR (eGFR < 90 mL/min/1.73 m2) n = 144				Normal eGFR (eGFR ≥ 90 mL/min/1.73 m2) n = 188
	Infarct Size *		LVEF		Infarct Size *		LVEF
	Rho	p -Value	Rho	p -Value	Rho	p -Value	Rho	p -Value
TMAO at admission	−0.28	0.016	0.20	0.068	−0.03	0.779	−0.004	0.968
TMAO at 24 h	−0.20	0.107	0.13	0.244	−0.17	0.081	0.008	0.935
TMAO at 4 months	0.24	0.031	−0.10	0.352	−0.12	0.221	0.09	0.351
Delta TMAO (admission–24 h)	−0.11	0.421	0.08	0.537	0.10	0.312	−0.05	0.638
Delta TMAO (24 h–4 months)	−0.35	0.004	0.19	0.100	0.01	0.914	−0.06	0.575
Delta TMAO (admission–4 months)	−0.49	<0.001	0.25	0.030	0.15	0.122	−0.18	0.059

* Infarct size as % of left ventricular thickness. Abbreviations: TMAO = trimethylamine N-oxide; LVEF = left ventricular ejection fraction; eGFR = estimated glomerular filtration rate.